Form 8-K · Current report
News Corp 8-K, filed Sep 11, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000199
Summary
News Corp filed a Form 8-K attaching its daily buy-back notifications to the Australian Securities Exchange under its 2025 Repurchase Program, which authorizes repurchases of up to an aggregate US$1 billion of its Nasdaq-listed Class A and Class B common stock. The notification reports 58,482 shares bought back on the previous day for US$1,712,399.75, bringing total purchases under the program to roughly US$471,009,719.
Key points
- News Corp is authorized to repurchase up to an aggregate US$1 billion of Class A and Class B common stock under the 2025 Repurchase Program.
- On the previous day it bought back 58,482 shares for US$1,712,399.75, at prices between US$29.08 and US$29.63.
- Cumulative repurchases under the program total 11,786,414 shares for US$306,402,283.11 based on consideration paid for the reported period.
- Total purchases under the 2025 Repurchase Program to date are approximately US$471,009,719.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.